SymbioPharm GmbH

Our mission is to use probiotic bacteria to improve health and wellbeing. For this purpose we explore the human microbiome: We are developing microbiological therapies for intestinal and respiratory health, as well as to improve immune function. Pioneering the understanding of the human microbiome as a basis we are a global leader in microbiome research and evidence based probiotics since 1954. State of the art technologies in our biotech-laboratory and close interaction with in-house physicians and medical scientists enable us to create first in kind innovative products, such as Symbioflor 1 one of the very first probiotic pharmaceuticals globally. We make use of the purely biological effect of natural occuring bacteria, to improve health and wellbeing in a number of indications. SymbioPharm is fully integrated from R&D to pharmaceutical production at our headquarter in Germany and is part of a privately held group of Institute of Microecology for microbiome diagnostics, A...